Latest news & press releases
Explore our news, announcements, and perspectives
- Press Release
Cumulus Oncology strengthens its leadership with new appointments to the Board of Directors and Scientific Advisory Team.
- Press Release
Cumulus Oncology and leadXpro Achieve Critical Milestone in GPR68 Drug Discovery Project
- Press Release
Cumulus Oncology Appoints Catherine Lewis La Torre to its Board of Directors
- Press Release
University of Eastern Finland (UEF) and Cumulus Oncology announce new collaboration
- Press Release
Launch of GIO Therapeutics, founded by Cumulus Oncology, to develop therapeutics targeting G protein-coupled receptors to treat cancer and inflammation
- Press Release
Cumulus Oncology and leadXpro Announce Collaboration to Develop Small Molecules against Novel Cancer-Focused GPCR Targets
- Press Release
Nodus Oncology announces acquisition of Basilea Pharmaceutica’s PARG inhibitor programme
- Press Release
Nodus Oncology launches, founded by Cumulus Oncology and in partnership with the Lead Discovery Center, to focus on developing first and best-in-class molecules inhibiting novel DNA damage response targets
- Press Release
Edinburgh cancer discovery accelerator Cumulus hires Chief Scientific Officer with ‘invaluable’ skills
- Press Release